Q1 2018 Holdings
Filed 2018-05-15 | 52 holdings | $64.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $24.3M | 371,739 | 37.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $22.4M | 278,536 | 34.7% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $9.2M | 525,538 | 14.3% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $7.3M | 286,668 | 11.4% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $272.4K | 2,563,200 | 0.4% |
| Nektar Therapeutics(NKTREUR)Call | COM | 640268108 | $162.7K | 1,530,900 | 0.3% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $114.9K | 1,104,022 | 0.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $90.4K | 4,088,229 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $58.9K | 1,918,350 | 0.1% |
| Inflarx NV(IFRX) | COM | N44821101 | $40.3K | 1,399,030 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $39.6K | 432,063 | 0.1% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $38.6K | 239,619 | 0.1% |
| Myokardia Inc | COM | 62857M105 | $37.4K | 767,363 | 0.1% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $34.4K | 3,600,954 | 0.1% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $31.5K | 1,300,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $28.5K | 1,519,891 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $26.7K | 719,985 | 0.0% |
| Avexis Inc | COM | 05366U100 | $23.7K | 192,094 | 0.0% |
| Quotient LTD | SHS | G73268107 | $20.2K | 4,290,852 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $20.2K | 1,880,880 | 0.0% |
| Tesaro Inc | COM | 881569107 | $20.0K | 350,000 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $16.1K | 957,821 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $15.8K | 191,112 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $14.7K | 1,314,118 | 0.0% |
| Quanterix Corp(QTRX) | COM | 74766Q101 | $14.4K | 847,789 | 0.0% |
| Anaptysbio Inc(ANAB)Call | COM | 032724106 | $13.5K | 129,400 | 0.0% |
| Menlo Therapeutics Inc | COM | 586858102 | $12.7K | 336,714 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $10.9K | 668,743 | 0.0% |
| Omeros Corp(OMER)Call | COM | 682143102 | $10.8K | 969,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $9.7K | 322,945 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $9.2K | 450,000 | 0.0% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $7.9K | 549,404 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $7.3K | 284,735 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $7.3K | 382,192 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $7.1K | 333,166 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COM | 48283N106 | $7.0K | 1,648,432 | 0.0% |
| Gemphire Therapeutics Inc | COM | 36870A108 | $6.8K | 1,041,635 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $5.4K | 3,392,234 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $5.3K | 191,108 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $5.1K | 685,958 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $4.9K | 125,000 | 0.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $4.9K | 773,816 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $4.1K | 573,208 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $3.8K | 607,903 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $3.3K | 382,139 | 0.0% |
| Evolus Inc(EOLS) | COM | 30052C107 | $3.1K | 342,400 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $2.8K | 71,667 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $1.9K | 82,988 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $1.8K | 478,111 | 0.0% |
| Oncobiologics Inc | *W EXP 05/18/201 | 68235M121 | $18 | 416,666 | 0.0% |